ESMO Preceptorship on Colorectal Cancer Valencia 2016

Oncology Meeting Resources

20 May - 21 May, Valencia, Spain

ESMO Preceptorship on Colorectal Cancer square

The ESMO Preceptorship on Colorectal Cancer Valencia 2016 was designed for learning about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings; understanding the importance of pathology and histoprognostic factors; learning about the management of patients after progression, side-effects of treatments and in special situations  

Presentations of the ESMO Preceptorship on Colorectal Cancer Valencia 2016 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful links

Presenter Presentation title Session title
F. Bibeau, FR The Point of View of the Pathologist Early Colorectal Cancer
H.R. Raab, DE State-of-the-art: Standard of Surgical Practice for Resectable Colorectal Cancer (Special Issues on Rectal Cancer) Early Colorectal Cancer
M. Saunders, UK State-of-the-art: Standard(s) of Radio/Chemotherapy for Rectal Cancer Early Colorectal Cancer
A. Cervantes, ES Adjuvant Chemotherapy of Rectal Cancer Early Colorectal Cancer
F. Bibeau, FR Microsatellite Instability and Other Molecular Markers: how Useful Are They? Adjuvant settings of colorectal cancer
J.Y. Douillard, FR Adjuvant Treatment for Stage III Colon Cancer Adjuvant settings of colorectal cancer
J.Y. Douillard, FR Adjuvant Treatment of Stage II: Which Patients to Treat? Adjuvant settings of colorectal cancer
M. Moschetta, IT A 32 Years Old CRC Patient Adjuvant settings of colorectal cancer
N. Vassos, DE Adenocarcinoma of Rectosigmoid with Synchronous Liver Metastasis Adjuvant settings of colorectal cancer
P. Jurcic, HR Acute Toxis Enterocolitis Caused by Capecitabine in Adjuvant Setting Adjuvant settings of colorectal cancer
P. Tolosa, ES A Metastatic Colorectal Cancer Long-Survival Patient Metastatic colorectal cancer, liver limited metastases
H.R. Raab, DE Resection of Liver Limited Metastasis (Resectable Cases, Group 0) Metastatic colorectal cancer, liver limited metastases
A. Cervantes, ES ESMO 2015 Consensus on Advanced Colorectal Cancer Metastatic colorectal cancer, liver limited metastases
J.Y. Douillard, FR Development of Conventional Chemotherapy in mCRC, BSC vs, Chemo, Biochemical Modulation, Oral Fluoropyrimidines, Development of Combination Chemotherapy Metastatic colorectal cancer, liver limited metastases
H.R. Raab, DE Resection of Liver Limited Metastasis (Resectable Cases, Group 0) Metastatic colorectal cancer, liver limited metastases